生物标志物 生物标志物
Tianyi Wang1, Yuyue Qiu1, Li Shang1
1Peking Union Medical College Hospital, Beijing, Beijing, China.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
概括
血pTau217水平有效地区分了阿尔茨海默病 (AD) 和其他神经退行性痴呆症. 这种血液生物标志物显示出与脑脊液 (CSF) 和PET成像相比的诊断准确性.
科学领域:
- 神经科学是一个神经科学.
- 生物标志物发现发现
- 诊断的准确性 诊断的准确性
背景情况:
- 将阿尔茨海默病 (AD) 与其他神经退行性痴呆症区分开来是临床上具有挑战性的.
- 血生物标志物为传统诊断方法 (如CSF分析和PET成像) 提供了一种不那么侵入性的替代方法.
- 评估各种等离子体生物标志物的诊断疗效对于早期和准确的AD诊断至关重要.
研究的目的:
- 评估血生物标志物的诊断性能,以区分AD与其他神经退行性疾病.
- 为了比较SIMOA和Lumipulse检测方法在血液生物标志物测量的有效性.
- 为了确定血生物标志物是否可以预测AD病理的准确度与既有方法相比较.
主要方法:
- 从医院痴呆症队列中招募了292名患者,这些患者有多种诊断,包括AD,CAA,CJD,FTD,HDLS,NIID,NPH,VAD和未确定的病因.
- 使用SIMOA和Lumipulse套件测量等离子体生物标志物 (Aβ42/40,pTau181,pTau217,GFAP,NFL).
- 跨诊断组生物标志物水平的统计比较和与CSF和PET成像结果的相关性.
主要成果:
- 血pTau217显示了AD和其他神经退行性疾病之间最显著的差异.
- 在CAA和CJD等特定疾病中观察到血pTau217水平升高,与AD相比.
- 血pTau217准确预测了CSF的Aβ状态 (准确度>0.9) 和Aβ PET/tau PET分类 (准确度高达0.977).
- 对于所有生物标志物,特别是pTau217.217,SIMOA和Lumipulse测量结果之间发现了强烈的相关性.
结论:
- 血pTau217是一种高效的生物标志物,用于区分痴呆症患者的AD病理.
- 血pTau217的诊断准确性与脑脊液 (CSF) 生物标志物和正子发射断层扫描 (PET) 成像可比.
- 基于血液的pTau217为AD诊断和管理提供了一个有希望的,最少侵入性的工具.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516